title: [Vegetotropic therapy and hypobaric hypoxic adaptation in gallbladder motor dysmotility].
abstract: The study of 67 chronic biliary patients (36 - gallbladder dysfunction, 25 acalculuous cholecystitis, 6 - cholelithiasis) was revealed their functional dysadaptation characterized by gallbladder dysmotility and autonomic dysfunction. Vegetotropic therapy (Propranolol, Metoclopramid, Atropine) according to the autonomic regulation activity has advantages in correction of the gallbladder dysmotility in comparison to the routine pharmacotherapy. Hypobaric hypoxic adaptation results in the increase of gallbladder emptying that opens perspectives for the non-pharmacological correction of the gallbladder hypokinetic dyskinesia.
authors.forename: A G
authors.initials: AG
authors.lastname: Nikolaeva
authors.forename: V N
authors.initials: VN
authors.lastname: Girsa
authors.forename: L M
authors.initials: LM
authors.lastname: Nemtsov
mesh_terms: D000222:Adaptation, Physiological / Q000502:physiology*; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects*; D001657:Biliary Dyskinesia / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D002765:Cholecystography; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005704:Gallbladder / Q000000981:diagnostic imaging / Q000294:innervation / Q000503:physiopathology; D016473:Gallbladder Emptying / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology*; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D000319:Adrenergic beta-Antagonists; D018492:Dopamine Antagonists; D010276:Parasympatholytics; C005317:drotaverin; D011433:Propranolol; D010208:Papaverine; D008787:Metoclopramide